Thomas Page Ph.D

Dr. Thomas Page brings over 35 years of Life Sciences experience, having worked at clinical development and CDMO companies in roles supporting operations, engineering, process development, and business development. His expertise spans a range of products, including blood-based therapies, vaccines, recombinant proteins, monoclonal antibodies (mAbs), and advanced therapy medicinal products. Over the course of his career, Dr. Page has led the design, construction, validation, and operation of assets valued at over $1 billion in both the public and private sectors. He holds numerous patents and publications and is passionate about advancing faster, better, and more cost-effective responses to pandemics and emerging health threats. Additionally, he is committed to supporting the next generation of biotechnologists and developing biotechnology hubs.